<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00685191</url>
  </required_header>
  <id_info>
    <org_study_id>ITHACA</org_study_id>
    <nct_id>NCT00685191</nct_id>
  </id_info>
  <brief_title>HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain</brief_title>
  <official_title>HIV-1 Viral Dynamics in Subjects Initiating Raltegravir Therapy in Spain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Germans Trias i Pujol Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Germans Trias i Pujol Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study purpose is to investigate plasma HIV-1 RNA dynamics in subjects initiating
      raltegravir-based salvage therapy and quantify the corresponding changes in levels of
      cellular HIV-1 DNA.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      First- and second-phase decay rates of plasma HIV-1 RNA and changes in the intracellular
      levels of HIV-1 proviral DNA and LTR circles will be measured in subjects starting salvage
      antiretroviral therapy including raltegravir in Spain.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>June 2008</start_date>
  <completion_date type="Actual">October 2009</completion_date>
  <primary_completion_date type="Actual">April 2009</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in viral load from day 0 to 7</measure>
    <time_frame>1 week</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Intracellular levels of HIV-1 proviral DNA and LTR circles</measure>
    <time_frame>24 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">15</enrollment>
  <condition>HIV Infections</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>HIV-1-infected subjects initiating raltegravir-including salvage therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Salvage antiretroviral therapy including raltegravir</intervention_name>
    <description>Initiation of raltegravir-including salvage antiretroviral therapy</description>
    <arm_group_label>1</arm_group_label>
    <other_name>RAL</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who have limited or no treatment options due to extensive antiretroviral drug
             resistance or drug intolerance.

          -  Subjects initiating raltegravir plus another fully active antiretroviral drug.

        Exclusion Criteria:

          -  Pregnancy, or fertile women willing to be pregnant.

          -  Active substance abuse or major psychiatric disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bonaventura Clotet, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital U. Germans Trias i Pujol</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital U. Germans Trias i Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>November 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2008</study_first_submitted>
  <study_first_submitted_qc>May 27, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 28, 2008</study_first_posted>
  <last_update_submitted>November 6, 2009</last_update_submitted>
  <last_update_submitted_qc>November 6, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 9, 2009</last_update_posted>
  <responsible_party>
    <name_title>LLuita Sida Foundation</name_title>
    <organization>LLuita Sida Foundation</organization>
  </responsible_party>
  <keyword>Raltegravir</keyword>
  <keyword>HIV</keyword>
  <keyword>dynamics</keyword>
  <keyword>viral load</keyword>
  <keyword>Treatment Experienced</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>HIV Infections</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Raltegravir Potassium</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

